Status:

RECRUITING

Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer

Lead Sponsor:

University of Bayreuth

Collaborating Sponsors:

University of Regensburg, Tumor Center Regensburg, Center for Quality Management and Health Services Research

G-BA Innovationsfonds

Conditions:

Lung Cancer

Quality of Life

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer ...

Detailed Description

A pathway with quality of life (QoL) diagnosis and therapeutic options for patients with breast cancer and colorectal cancer has been successfully designed, implemented, and evaluated as guided by the...

Eligibility Criteria

Inclusion Criteria:

  1. primary diagnosis of lung cancer (ICD C33/C34, all stages)
  2. treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospital Bamberg);
  3. difference between date of histology and date of study entry not exceeding 2 months;
  4. informed consent;

Exclusion Criteria:

  1. unavailability of a study clinician for patient recruitment;
  2. patient misclassified in the candidate list (no primary diagnosis, no lung tumour);
  3. coordinating practitioner refuses trial participation;
  4. patient outside the defined study region (Germany, Bavaria: Upper Palatinate, Lower Bavaria, Upper Franconia);
  5. age under 18 years;
  6. pregnancy/ breastfeeding;
  7. patient unable to fill out the QoL questionnaire (physical, psychological, cognitive, language reasons);
  8. patient refuses trial participation

Key Trial Info

Start Date :

February 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 15 2025

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT06252233

Start Date

February 15 2024

End Date

August 15 2025

Last Update

December 16 2024

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Klinikum Bamberg

Bamberg, Germany, 96049

2

Hospital Bayreuth

Bayreuth, Germany, 95445

3

Klinikum Coburg GmbH

Coburg, Germany, 96450

4

Caritas Krankenhaus St. Maria Donaustauf

Donaustauf, Germany, 93093